CRi’s New Vectra(TM) Platform Rapidly Analyzes Tissue Slides and Microarrays in Brightfield and Fluorescence
The Vectra system utilizes CRi’s inForm(TM) Advanced Image Analysis Software, which leverages proprietary machine-learning technology to make it possible to better understand inter-molecular interactions within individual cells.
“Vectra’s intelligent scanning approach provides a more efficient and faster alternative to whole-slide scanning,” said
to visualize using any other means.”
Compared with conventional means, the new instrument enables much more accurate and dramatically faster imaging of breast cancer and lymphoma tissue, as well as prostate and kidney specimens. Preclinical studies that formerly took weeks or months scanning hundreds or thousands of slides can now be done in days.
According to Dr.
“Vectra and InForm go beyond the capabilities of a routine microscope or whole slide scanner by allowing high-order mutliplexing with advanced cytometric analysis.”
Cambridge Research & Instrumentation, Inc (CRi) is a
For more information visit our website at http://www.cri-inc.com/vectra or contact:
Ross Nakatsuji CRi Marketing/Sales Group Leader 35-B Cabot Road, Woburn, MA 01801 USA (P) 1-781-935-9099, extension 177, (C) 1-781-405-4000, (E) email@example.com
SOURCE Cambridge Research & Instrumentation, Inc.